Navigating the Post-Diagnosis Landscape: Insights from the Ehlers-Danlos Community on Symptom Management on October 24, 2026 Posted by
Financial Security in the Golden Years: Exploring the Role of Reverse Mortgages in Long-Term Care Planning on October 24, 2026 Posted by
Beyond the Nap: Unveiling the Holistic Burden of Narcolepsy Through the ‘All of Us’ Research Program on October 24, 2026 Posted by
Moving Toward Mobility: New Study Links Consistent Exercise to Slower Parkinson’s Progression on October 24, 2026 Posted by
Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
Navigating the Post-Diagnosis Landscape: Insights from the Ehlers-Danlos Community on Symptom Management on October 24, 2026 Posted by
Financial Security in the Golden Years: Exploring the Role of Reverse Mortgages in Long-Term Care Planning on October 24, 2026 Posted by
Beyond the Nap: Unveiling the Holistic Burden of Narcolepsy Through the ‘All of Us’ Research Program on October 24, 2026 Posted by
Moving Toward Mobility: New Study Links Consistent Exercise to Slower Parkinson’s Progression on October 24, 2026 Posted by
Posted in Medical Innovations Celea Therapeutics Secures $180M to Advance Next-Generation IPF Treatment on July 2, 2026
Posted in Medical Innovations Ipsen Accelerates Rare Disease Strategy with Strategic Acquisition of Memo Therapeutics on July 1, 2026
Posted in Medical Innovations Beeline Medicines Secures $426M War Chest to Redefine Autoimmune Therapeutics on July 1, 2026
Posted in Medical Innovations Novartis Partners with Antares Therapeutics: A Strategic Pivot in Oncology R&D on June 26, 2026
Posted in Digital Health Tools AbbVie Doubles Down on Immunology: The Strategic $135.11-Per-Share Acquisition of Apogee Therapeutics on June 23, 2026
Posted in Digital Health Tools A Psychedelic Paradigm Shift: Definium Therapeutics’ LSD-Based Therapy Clears Key Phase 3 Hurdle on June 22, 2026
Posted in Medical Innovations AbbVie’s $10.9 Billion Acquisition of Apogee Therapeutics: A Strategic Pivot in Immunology on June 22, 2026
Posted in Medical Innovations CAMPfield Therapeutics Emerges with $180M Series A to Disrupt the IBD Treatment Landscape on June 18, 2026
Posted in Medical Innovations Clinical Ambiguity: Edgewise Therapeutics’ Phase 2 Heart Data Leaves Investors Divided on June 18, 2026
Posted in Medical Innovations The Next Frontier in Migraine Relief: Inside Vedana Therapeutics’ Quest to Disrupt the Market on June 17, 2026
